Accreditation/Credit Designation

Physicians’ Education Resource^®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC, designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Acknowledgment of Support

This activity is funded by PER^®.

Targeting TAp63 in Breast Cancer

Release Date: May 26, 2021
Expiration Date: May 26, 2022

Activity Overview

This continuing medical education (CME) activity is designed to inform health care providers involved in the care of patients with breast cancer of emerging data regarding the physiologic role of TAp63 and the rationale for targeting TAp63 for the treatment of breast cancer. This in-depth program will cover recent data from the preclinical studies of TAp63, as well as strategies being explored for the development of therapies targeting TAp63 in breast cancer.

Acknowledgement of Commercial Support

This activity is funded by PER^®.

Instructions for This Activity and Receiving Credit

Complete the activity (including pre- and post-activity assessments).
Answer the evaluation questions.
Request credit using the drop-down menu.

You may immediately download your certificate.

Learning Objectives

Upon successful completion of this activity, you should be better prepared to:

Describe the physiologic function of TAp63 in breast cancer
Explain the rationale for targeting TAp63 as a mechanism for treating breast cancer

Faculty, Staff, and Planners’ Disclosures

In accordance with ACCME Guidelines, PER^® has identified and resolved all COI for faculty, staff, and planners prior to the start of this activity by using a multistep process.

Faculty

Leif W. Ellisen, MD, PhD
Program Director, Breast Medical Oncology
Massachusetts General Hospital Cancer Center
Professor of Medicine
Harvard Medical School
Boston, MA

Disclosures: no relevant financial relationships with commercial interests.

The staff of Physicians' Education Resource^®, LLC (PER^®) have no relevant financial relationships with commercial interests to disclose.

This activity was written by PER^® editorial staff under faculty guidance and review. The Q&A portion of the activity was transcribed from a recorded interview with the faculty and edited by faculty and PER^® editorial staff for clarity.

Off-Label Disclosure and Disclaimer

This activity may or may not discuss investigational, unapproved, or off-label use of drugs. Learners are advised to consult prescribing information for any products discussed. The information provided in this accredited activity is for continuing education purposes only and is not meant to substitute for the independent clinical judgment of a healthcare professional relative to diagnostic, treatment, or management options for a specific patient’s medical condition. The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of PER^® or any company that provided commercial support for this activity.